Idarubicin plus attenuated high-dose cytosine arabinoside in the treatment of relapsed and refractory acute leukemia.
Cavanna
L
L
Di Stasi
M
M
Fornari
F
F
Civardi
G
G
Sbolli
G
G
Moretto
M
M
Buscarini
L
L
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage*; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D009364:Neoplasm Recurrence, Local
D003561:Cytarabine; D015255:Idarubicin